Regorafenib and reactive metabolite of sunitinib activate inflammasomes: Implications for multi tyrosine kinase inhibitor-Iiduced immune related adverse events
Ryuji Kato(Nagoya University), Yoshio Ijiri(Osaka University of Pharmaceutical Sciences)
Cited by 4
Related Papers
The 2-Hydroxyiminostilbene Metabolite of Carbamazepine or the Supernatant from Incubation of Hepatocytes with Carbamazepine Activates Inflammasomes: Implications for Carbamazepine-Induced Hypersensitivity Reactions
|Drug Metabolism and Disposition|2019|27
Reactive metabolite of gefitinib activates inflammasomes: implications for gefitinib-induced idiosyncratic reaction
|The Journal of Toxicological Sciences|2020|26